Activation of AP-1 and SP1 correlates with wound growth factor gene expression in glucan-treated human fibroblasts
International Immunopharmacology, ISSN: 1567-5769, Vol: 2, Issue: 8, Page: 1163-1172
2002
- 47Citations
- 1Usage
- 28Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations47
- Citation Indexes47
- 47
- CrossRef37
- Usage1
- Abstract Views1
- Captures28
- Readers28
- 28
Article Description
Glucan is a natural product immunomodulator that has been reported to enhance early wound repair. The mechanism of glucan-stimulated wound repair was thought to be indirect via macrophage release of wound growth factors. However, recent data indicate that there are glucan-specific receptors on human fibroblasts that can modulate cellular function following interaction with the glucan ligand. In this study we examined the effect of glucan on activation of the transcription factors activator protein-1 (AP-1) and specificity protein-1 (Sp1) in normal human dermal fibroblasts. AP-1 and Sp1 are involved in the regulation of cytokine and procollagen genes. In addition, we evaluated the effect of glucan on wound growth factor and vascular endothelial growth factor (VEGF) mRNA expression in primary cultures of normal human dermal fibroblasts. Glucan (1 μg/ml) stimulated fibroblast AP-1 and Sp1 activation in a time-dependent manner, although the temporal kinetics varied between the two transcription factors. AP-1 binding activity was increased ( p <0.05) at early time intervals (1, 2, 4, 8 and 12 h), while Sp1 nuclear binding activity was increased ( p <0.05) at later time intervals (12, 24, 36 and 48 h). Glucan (1 μg/ml) stimulated fibroblast expression of neurotrophin 3 (NT-3), platelet derived growth factor A (PDGF-A), platelet derived growth factor B (PDGF-B), fibroblast growth factor acidic (aFGF), fibroblast growth factor basic (bFGF), transforming growth factor alpha (TGFα), transforming growth factor beta (TGFβ) and VEGF mRNA at 8 h.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1567576902000826; http://dx.doi.org/10.1016/s1567-5769(02)00082-6; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0035993219&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/12349953; https://linkinghub.elsevier.com/retrieve/pii/S1567576902000826; http://linkinghub.elsevier.com/retrieve/pii/S1567576902000826; http://api.elsevier.com/content/article/PII:S1567576902000826?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S1567576902000826?httpAccept=text/plain; https://dc.etsu.edu/etsu-works/19016; https://dc.etsu.edu/cgi/viewcontent.cgi?article=20282&context=etsu-works; http://dx.doi.org/10.1016/s1567-5769%2802%2900082-6; https://dx.doi.org/10.1016/s1567-5769%2802%2900082-6
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know